Refining patient selection for neoadjuvant chemotherapy before radical cystectomy - Wikidata - awgldk - TriplyDB

Refining patient selection for neoadjuvant chemotherapy before radical cystectomy

Refining patient selection for neoadjuvant chemotherapy before radical cystectomy

http://www.wikidata.org/entity/Q30408866

about

Risk based neoadjuvant chemotherapy in muscle invasive bladder cancer Standard cystectomy fits all: truth or myth?Systemic, perioperative management of muscle-invasive bladder cancer and future horizons.Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trial.Defining the potential of neoadjuvant chemotherapy use as a quality indicator for bladder cancer care.Treatment of muscle-invasive bladder cancer in Canada: A survey of genitourinary medical oncologists and urologists.Evaluation and Management of the Geriatric Urologic Oncology Patient.PET/CT versus conventional CT for detection of lymph node metastases in patients with locally advanced bladder cancer.Immediate Radical Cystectomy for Massive Bleeding of Bladder Cancer Micropapillary Bladder Cancer: Insights from the National Cancer Database New discoveries in the molecular landscape of bladder cancer.Uptake of neoadjuvant chemotherapy for invasive bladder cancer.Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patients.Treatment and management of high-grade T1 bladder cancer: what should we do after second TUR?Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.Dose dense MVAC prior to radical cystectomy: a real-world experience.Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer.Current Concepts in the Management of Muscle Invasive Bladder Cancer.Contemporary update on neoadjuvant therapy for bladder cancer.Pathology review impacts clinical management of patients with T1-T2 bladder cancer In cystectomy specimens with bladder cancer whole organ embedding increases the detection rate of histopathological parameters, but not of those with prognostic significance.Utility of Clinical Risk Stratification in the Selection of Muscle-Invasive Bladder Cancer Patients for Neoadjuvant Chemotherapy: A Retrospective Cohort Study.Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? | Opinion: Yes.Reporting trends and prognostic significance of lymphovascular invasion in muscle-invasive urothelial carcinoma: a population-based study.Impact of High-risk Features and Effect of Neoadjuvant Chemotherapy in Urothelial Cancer Patients with Invasion into the Lamina Propria on Transurethral Resection in the Absence of Deep Muscle Invasion.Characteristics and clinical significance of histological variants of bladder cancer.Do we have biomarkers to predict response to neoadjuvant and adjuvant chemotherapy and immunotherapy in bladder cancer?Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature.Role of Radical Cystectomy in Non-Organ Confined Bladder Cancer: A Systematic Review.Peri-operative chemotherapy for muscle-invasive bladder cancer: status-quo in 2017.Accuracy and prognostic value of variant histology and lymphovascular invasion at transurethral resection of bladder.A Genomic-clinicopathologic Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer.Neoadjuvant induction dose-dense MVAC for muscle invasive bladder cancer: efficacy and safety compared with classic MVAC and gemcitabine/cisplatin.Assessing Cancer Progression and Stable Disease After Neoadjuvant Chemotherapy for Organ-confined Muscle-invasive Bladder Cancer.Hyperthermia and radiotherapy in bladder cancer

P2860

Q26773664-A26B9845-3B55-451C-BCE1-2A366FE0722F Q26774347-C9D9D227-121B-4F48-8C21-99F8E6DE1C5B Q30240816-C352B9DB-1AFC-4AB8-82C0-A2872B5C455D Q30870825-CA635762-3CDB-4F7E-BCC9-B91B9AD1F3C3 Q34021124-0773E142-069E-49C9-8D59-83FDF8CFA654 Q34435978-2464C5BB-DFA9-4A49-85F3-3441F140633F Q35063815-CD344ED6-0961-4C36-BEE4-224278FC369C Q35751887-22FF8BA0-4A5B-4346-B293-671BE62CC690 Q36446891-9EEAC313-8DFC-4FAE-85B2-849487A10AC1 Q37530374-00CADCA3-E166-4618-92B2-EAF1C2308CB6 Q37578747-C856D476-C016-41D6-B7C7-CB9703465203 Q37726904-F964CF48-687C-4FA4-8BE7-137AC20E57E5 Q38218163-736FF346-CBD7-47B0-883C-A28AB1CD31A5 Q38316336-1896F1AE-B68B-4E11-AC95-752C96238C9D Q38689374-530F88B8-9F03-4CCB-AD2A-DAE1B738C22B Q38720755-FD286190-2629-404B-88C4-896C09CA8D85 Q38983687-01A0312F-8774-4458-AB36-3581BE5BAE20 Q39105784-61578DE2-8B32-47E6-8A57-0386259C1D46 Q39177293-6BF814EF-8A16-426E-BDC8-745E40CA7713 Q39399826-38ED43A5-C8A3-484D-8AB5-AC600A6EDA21 Q41441646-6563FCCD-88E4-4035-9FBE-05CB378B4BF4 Q42327574-3AF66EC7-BF9A-4542-A519-2BC998F3C173 Q42350221-14382BC8-F474-4404-9E3A-86D91135212A Q43557462-A96CC74E-4DD7-4CD8-B59A-E664FDFF587A Q47269209-9240A90E-C79A-487D-89A4-140A4A0BBDD7 Q47998264-440F7B67-2559-4BD4-8DC3-448EB9EE4566 Q49246529-E3E5B29F-CC75-401B-B22E-368A744E7D89 Q49380161-193B76A1-1206-422D-90C5-9FE1466CFDD0 Q49420756-B66EE969-82C4-4BDA-9C8D-4299DA97A9D8 Q49526759-79A10A7A-2903-4C4A-883D-C03925A0F6C1 Q50062164-F13E65D1-E575-4DE5-9D02-F46B9FEA0DEC Q52588104-8AEE252B-EDB4-4360-86E8-82A7F7CBC8D3 Q53422101-AACAE7E4-33B0-40D8-BD02-41E9BB7D4DA5 Q54004930-EA449F78-7AA1-4115-8A9C-13AB1A4B3B5B Q58417806-333C7DEC-06EE-4BEC-A9E6-BDCF728CB17F

P2860

Refining patient selection for neoadjuvant chemotherapy before radical cystectomy

http://www.wikidata.org/entity/Q30408866

description

2013 nî lūn-bûn

@nan

2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Refining patient selection for neoadjuvant chemotherapy before radical cystectomy

@ast

Refining patient selection for neoadjuvant chemotherapy before radical cystectomy

@en

type

label

Refining patient selection for neoadjuvant chemotherapy before radical cystectomy

@ast

Refining patient selection for neoadjuvant chemotherapy before radical cystectomy

@en

prefLabel

Refining patient selection for neoadjuvant chemotherapy before radical cystectomy

@ast

Refining patient selection for neoadjuvant chemotherapy before radical cystectomy

@en

P1433

Q30408866-43F43452-451D-4F2D-96D0-F27B1D61C2B4

P1476

Q30408866-48395BBF-3F55-4B0F-B773-94F6D6B0E87B

P2093

Q30408866-1031327D-E078-4FEE-90F1-131F17D26C6C

Q30408866-18E3239F-3BD1-4ADE-B531-70FBA2FAAC01

Q30408866-240B4FAC-38EE-46CE-9CF7-FB9C412D67C3

Q30408866-28EF0C15-5F31-4379-8352-8C6DAA183BBE

Q30408866-297C23F5-0647-4715-935D-88DAF36C1233

Q30408866-3B078D2C-C737-474B-9178-169BD49824F6

Q30408866-5CD0656F-248F-45A5-8619-1827358CBB01

Q30408866-60B760E0-50FB-43FB-A19A-B8FCAEEFC6B5

Q30408866-871E36AA-82E6-4D60-9FA9-ED7893CD1EAF

Q30408866-957F0D20-D01F-4677-A15B-7F2A6F1D4C64

P2860

Q30408866-047E7440-FD7C-487E-B50E-5F46218E3279

Q30408866-06B9237F-5307-4FEE-AC66-55ECEAB2F757

Q30408866-2851DAF4-910A-4A10-83F4-44E32DB12528

Q30408866-356F9413-A0C4-4901-8F3D-0AE17B3C2837

Q30408866-3D1DEFA1-865F-4D5A-A28A-EF9F6B409753

Q30408866-49584E57-F8A0-4E10-9D2F-E3BBE20EF2B5

Q30408866-6CA609B3-0411-4F30-BFD3-6314F86D0AB5

Q30408866-7091EA44-43EA-4199-812F-24A5905EA9BB

Q30408866-7C3443BF-7835-49AE-BFB2-E6BD0CBDF4F0

Q30408866-A522262B-58A5-484D-8089-A4BAC85D842D

P304

Q30408866-036426C9-4116-44C1-BA11-79CB8CC203ED

P31

Q30408866-B45E1E64-B703-4160-ACD2-551A2207F562

P356

Q30408866-949675D2-76B9-4C86-AE49-6204EB40A630

P407

Q30408866-9FFBCCCB-C607-44BF-9CB0-5B1449DFA295

P433

Q30408866-F483C04F-5E98-487C-A46A-9E8843260559

P478

Q30408866-F1102CB5-10C4-488A-AB1C-922351304A3A

P50

Q30408866-D4E91065-F61C-4E2D-9ED8-19F32B863B4D

P577

Q30408866-DAB7D5E4-80CC-4D4C-9C9D-9E3B1DE62F70

P698

Q30408866-C2097F67-56AA-4B44-9C28-6EDDDF10BD0D

P921

Q30408866-3E7223E5-CCCA-4152-BC6E-D7BF139C82E5

Q30408866-BC495012-21FD-4E87-84D4-E2BFDD7A9F65

P932

Q30408866-FB0DD4E9-BFB2-471B-9905-391F8B9883DF

P356

J.JURO.2013.07.061

P1433

The Journal of Urology

P1476

Refining patient selection for neoadjuvant chemotherapy before radical cystectomy

@en

P2093

Arlene Siefker-Radtke

http://www.w3.org/2001/XMLSchema#string

Ashish M Kamat

http://www.w3.org/2001/XMLSchema#string

Bogdan Czerniak

http://www.w3.org/2001/XMLSchema#string

Colin P N Dinney

http://www.w3.org/2001/XMLSchema#string

H Barton Grossman

http://www.w3.org/2001/XMLSchema#string

Jie Cai

http://www.w3.org/2001/XMLSchema#string

Matthew F Wszolek

http://www.w3.org/2001/XMLSchema#string

Neema Navai

http://www.w3.org/2001/XMLSchema#string

Randall E Millikan

http://www.w3.org/2001/XMLSchema#string

Rian J Dickstein

http://www.w3.org/2001/XMLSchema#string

P2860

The presence of lymphovascular invasion in radical cystectomy specimens from patients with urothelial carcinoma portends a poor clinical prognosis.

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.

Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis.

Neoadjuvant chemotherapy for bladder cancer.

Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis.

Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience.

Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients.

Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer.

Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy.

Preoperative hydronephrosis as an indicator of survival after radical cystectomy.

P304

40-47

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JURO.2013.07.061

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

191

http://www.w3.org/2001/XMLSchema#string

P50

Siamak Daneshmand

P577

2013-07-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23911605

http://www.w3.org/2001/XMLSchema#string

P921

P932

4158919

http://www.w3.org/2001/XMLSchema#string